+499.5%
MRNA vs USAR
+27.9%
+471.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | USAR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.5% | -1.8% | -2.2% |
| 7D | +5.5% | -2.1% | +7.6% | +5.7% |
| 30D | +158.7% | +2.6% | +156.1% | +157.4% |
| 3M | +182.1% | -35.0% | +217.1% | +196.2% |
| 6M | +151.8% | -6.9% | +158.7% | +148.8% |
| YTD | +393.6% | +48.0% | +345.6% | +348.2% |
| 1Y | +499.5% | +24.8% | +474.7% | +439.6% |
| All | +499.5% | +27.9% | +471.6% | +439.6% |
Cumulative growth
Daily Returns
Daily percentage return beside USAR.
Daily Out/Under-Performance
Portfolio return minus USAR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × USAR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded USAR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling